Fig 1: Ephrin B2 antibody treatment inhibited AiV pseudovirus cell entry.(A-B) Huh7 cells were pre-incubated with GFP antibody or Ephrin B2 antibody at the indicated concentrations for 2 hours, then transduced with NiV (A) or AiV (B) pseudoviruses. Luciferase activity was measured 48 hours after transduction. (C) Schematic diagram of AiV G mutants. The mutation sites are highlighted in red. (D) HEK293T cells overexpressing EFNB2, EFNB3, or a control vector were transduced with AiV pseudoviruses bearing AiV G (WT), W494A or E523A mutant. Statistical significance was determined by two-tailed Student’s t-test (ns, not significant; *p < 0.05, **p < 0.01, ***p < 0.001).
Fig 2: The glycoprotein of AiV binds to human ephrin B2 and ephrin B3.(A) Coimmunoprecipitation of AiV glycoprotein and ephrin B2. HEK293T cells were co-transfected with EFNB2 and FLAG tagged NiV or AiV glycoprotein (G) expression vector. Forty-eight hours after transfection, the cell lysates were subjected to immunoprecipitation using anti-FLAG magnetic beads, followed by Western blotting with the indicated antibodies. (B) Schematic diagram of AiV glycoprotein and fusion protein-mediated syncytia formation. (C) HEK293T cells transfected with AiV glycoprotein and fusion protein were co-cultured with HEK293T cells expressing GFP and EFNB2, EFNB3, or the vector control. The cells were imaged via fluorescence microscopy to visualize the syncytia. Scale bar = 100 μm. (D) Quantification of syncytia from eight randomly selected microscopic fields per group. The data are representative of three independent experiments. Statistical significance was determined by two-tailed Student’s t test, where ***p < 0.001.
Fig 3: Evolutionarily conserved EFNB2 recognition architecture in henipaviral glycoproteins.(A) AiV G (blue)–EFNB2 (purple) complex structure predicted by AlphaFold3. (B) Experimental NiV G (yellow)–EFNB2 (pink) complex structure (PDB: 2VSM). (C) Structural superposition of AiV G-EFNB2 complex and NiV G-EFNB2 complex revealing conserved binding topology. (D,E) Receptor-binding interfaces of AiV (blue) and NiV (yellow), highlighting conserved motif positions. (F) Superimposed interfaces (green) demonstrate spatial overlap of core receptor-contact residues across both viruses.
Fig 4: AiV utilizes ephrin B2 and ephrin B3 as functional receptors.(A) HEK293T cells overexpressing EFNB1, EFNB2, EFNB3, or a control vector were transduced with pseudotyped AiV or NiV particles. This experiment was performed in triplicate as independent biological replicates. (B-C) HEK293T cells overexpressing EFNB2 (B) or EFNB3 (C) were transfected with the corresponding EFNB2, EFNB3 shRNA or scrambled shRNAs. Knockdown efficiency was confirmed by Western blotting. These experiments were conducted in duplicate as independent biological replicates. (D) EFNB2, EFNB3 knockdown or control cells were transduced with AiV pseudoviruses and the luciferase activity was measured. This experiment was performed in triplicate as independent biological replicates. (E-F) SH-SY5Y cells were transduced with lentiviral vectors expressing EFNB2 or scrambled shRNAs. EFNB2 knockdown was confirmed by Western blotting (E). The knockdown and control cells were transduced with AiV pseudoviruses (F). (G-H) Similarly, SH-SY5Y cells were transduced with lentiviral vectors expressing EFNB3 or scrambled shRNAs. The knockdown efficiency of EFNB3 was confirmed by Western blotting (G). The knockdown and control cells were transduced with AiV or NiV pseudoviruses (H). Statistical significance was determined by two-tailed Student’s t-test (ns, not significant; *p < 0.05, **p < 0.01, ***p < 0.001).
Fig 5: Identification of a viral glycoprotein with conserved residues critical for EFNB2 binding from Chinese bat metagenomes.(A) Flowchart for identification of viral glycoproteins that bind to human ephrin B2. (B) Sequence analysis of key residues in glycoprotein proteins from NiV (AAK29088.1), HeV (AAC83193.2), Ghana virus (GhV, YP_009091838.1), Cedar virus (CedV, YP_009094086.1) and the new henipavirus (XRT74647.1) that interact with the receptor ephrin B2. The key residues are highlighted in red. (C) The genome size and organization of AiV and NiV. The coding regions for each gene are shown and depicted in color. Noncoding intergenic regions are indicated by black lines. (D) Schematic diagram of the phosphoproteins (P) of NiV (AAF73378.1) and AiV (XRT74644.1). Colored bars: N-terminal domain (NTD, brown), oligomerization domain (OD, gray), and C-terminal X domain (XD, blue). (E) Schematic of the P gene of AiV. The alternative translation start sites are indicated by black triangle. The putative mRNA editing site is indicated by solid circle. (F) Sequence alignment of the putative mRNA editing site across members of the genus Henipavirus.
Supplier Page from Sino Biological, Inc. for Mouse Ephrin B2 Gene ORF cDNA clone expression plasmid, C-HA tag